OXiGENE is a biopharmaceutical company whose mission is finding and developing new and improved therapeutics that can deliver significant medical benefits to patients with cancer and sight-threatening eye diseases and conditions.

Thursday, June 24, 2010
OXiGENE Announces Clinical Data From FACT Study to be Presented at the 14th International Thyroid Congress

Tuesday, June 22, 2010
OXiGENE Presents Encouraging Preclinical Data on ZYBRESTAT Ophthalmology Program